RE:New Press Release - Kane Biotech Announces Third Quarter 2024 Financial ResultsWell... 3rd QTR numbers are out and they look pretty decent to me especially on the expenses front.
If you take into account everything that happened during the past QTR, it is pretty amazing to see that they've been able to keep good control over the expenses. The service fees are hign so we can imagine that this revenue will disappear sooner than later but at the same time Revyve sales are growing, will see how it goes in the upcoming QTR's but, I'm good with how this story is unfolding.
I've watched Mr. Edwards video...the list of 3rd QTR achievements are quite impressive and there is still some interesting announcements to be made before the end of the calendar year namely, the UofMiami acne trials, the first sales and delivery of Revyve wound gel and a distributorship deal here in Canada...
GLTA!